 |  |
Merck unveils microbiology application lab in Jigani, Bengaluru
Supports capability built-up in microbial quality control in Pharma, and biopharma industry Merck invests €200,000 in the infrastructure of the new lab at Jigani
Biotechnology | 21/07/2022 | By Sudeep Soparkar | 627
KBI Biopharma, Selexis open expanded facility in Geneva, Switzerland
The ~94,000 square-foot facility will house new laboratories to support Selexis’ unique technical cell line workflows and KBI’s process development and cGMP manufacturing
Biotechnology | 11/07/2022 | By Sudeep Soparkar | 596
Two ImmunoINSIGHTS contracts signed by Oncimmune
Oncimmune Holdings announces the signing of two new ImmunoINSIGHTS commercial contracts.
Biotechnology | 15/04/2022 | By Sudeep Soparkar | 513
Global diseases treatment with mRNA to be researched by Moderna and IAVI together
Moderna and IAVI, a nonprofit scientific research organization, are teaming up to use mRNA to develop new therapies for a range of diseases like HIV / AIDS, Tuberculosis, anti-microbial-resistant enteric infection and COVID-19.
Biotechnology | 12/04/2022 | By Sudeep Soparkar | 458
CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation declared the most recent subsidizing grant under its US$ 200 million program to propel the improvement of antibodies that give wide assurance against SARS-CoV-2 variations and other betacoronaviruses.
Biotechnology | 09/04/2022 | By Sudeep Soparkar | 245
Collaboration between ICMR and Pharma companies to develop Dengue vaccine
With the rise in dengue cases across the country, the Indian Council of Medical Research (ICMR) has embarked on an initiative aiming to facilitate development of dengue vaccine. Vaccine manufacturer and pharma companies who have developed or have license of tetravalent dengue vaccine candidate and have successfully completed its phase I and phase II
Biotechnology | 07/03/2022 | By Darshana | 463
The US Food and Drug Administration's (FDA) Office of Orphan Products Development (OOPD) has formally granted Orphan Drug Designation (ODD) to Innovent Biologics's fully-human B-Cell Maturation Antigen (BCMA)-targetted Chimeric Antigen Receptor (CAR) T-cell therapy
Biotechnology | 17/02/2022 | By Darshana | 629
Proteon Pharmaceuticals India, a subsidiary of Proteon Pharmaceuticals SA Poland, announced it will focus on the development of bacteriophages as a sustainable alternative to antibiotics in the poultry industry
Biotechnology | 18/10/2021 | By Darshana | 504
An integrated clinical decision support system (CDSS) using artificial intelligence (AI) could be useful to health workers in primary and secondary healthcare settings to overcome the present challenges including a lack of adequate manpower in the system, according to a study sponsored by NITI Aayog and UK-Department of International Trade
Biotechnology | 01/09/2021 | By Darshana | 286
Nucleome unveils South Asia's largest genomics research centre in Hyderabad
In a move that will mark the beginning of a new era in India's genomics capability, Nucleome Informatics has unveiled South Asia's largest and most advanced genomics facility, NKC Centre for Genomics Research in Hyderabad
Biotechnology | 27/08/2021 | By Darshana | 316
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy